Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zile

Showing results (941-950 of 1,060) with videos related to

Pageof 106
Sort By:
JACC. Heart Failure|June 6, 2024
Sacubitril/Valsartan in Patients With Heart Failure and Deterioration in eGFR to <30 mL/min/1.73 m<sup>2</sup>Safia Chatur, Iris E Beldhuis, Brian L Claggett, et al.
European Journal of Heart Failure|May 1, 2020
The prevalence and importance of frailty in heart failure with reduced ejection fraction - an analysis of PARADIGM-HF and ATMOSPHEREPooja Dewan, Alice Jackson, Pardeep S Jhund, et al.
BMJ Open|April 19, 2020
Canada-wide mixed methods analysis evaluating the reasons for inappropriate emergency department presentation in patients with a history of atrial fibrillation: the multicentre AF-ED trialKathryn Lauren Hong, Corinne Babiolakis, Brigita Zile, et al.
European Journal of Heart Failure|July 29, 2020
Prevalence and incidence of intra-ventricular conduction delays and outcomes in patients with heart failure and reduced ejection fraction: insights from PARADIGM-HF and ATMOSPHERESøren Lund Kristensen, Davide Castagno, Li Shen, et al.
American Journal of Physiology. Heart and Circulatory Physiology|October 22, 2002
Deficiency of TIMP-1 exacerbates LV remodeling after myocardial infarction in miceEsther E J M Creemers, Jeniffer N Davis, Andrea M Parkhurst, et al.
Circulation|November 20, 2014
International geographic variation in event rates in trials of heart failure with preserved and reduced ejection fractionSøren L Kristensen, Lars Køber, Pardeep S Jhund, et al.
JACC. Heart Failure|October 10, 2024
Race in Heart Failure: A Pooled Participant-Level Analysis of the Global PARADIGM-HF and PARAGON-HF TrialsHenri Lu, Brian L Claggett, Milton Packer, et al.
European Journal of Heart Failure|April 1, 2024
Interatrial shunt therapy in advanced heart failure: Outcomes from the open-label cohort of the RELIEVE-HF trialJosep Rodés-Cabau, JoAnn Lindenfeld, William T Abraham, et al.
JACC. Heart Failure|April 15, 2019
Prior Pacemaker Implantation and Clinical Outcomes in Patients With Heart Failure and Preserved Ejection FractionLi Shen, Pardeep S Jhund, Kieran F Docherty, et al.
European Journal of Heart Failure|April 17, 2023
Impact of multimorbidity on mortality in heart failure with reduced ejection fraction: which comorbidities matter most? An analysis of PARADIGM-HF and ATMOSPHEREPooja Dewan, João Pedro Ferreira, Jawad H Butt, et al.
Pageof 106

Showing results (941-950 of 1,060) with videos related to

Sort By:
Pageof 106
JACC. Heart Failure|June 6, 2024
Sacubitril/Valsartan in Patients With Heart Failure and Deterioration in eGFR to <30 mL/min/1.73 m<sup>2</sup>Safia Chatur, Iris E Beldhuis, Brian L Claggett, et al.
European Journal of Heart Failure|May 1, 2020
The prevalence and importance of frailty in heart failure with reduced ejection fraction - an analysis of PARADIGM-HF and ATMOSPHEREPooja Dewan, Alice Jackson, Pardeep S Jhund, et al.
BMJ Open|April 19, 2020
Canada-wide mixed methods analysis evaluating the reasons for inappropriate emergency department presentation in patients with a history of atrial fibrillation: the multicentre AF-ED trialKathryn Lauren Hong, Corinne Babiolakis, Brigita Zile, et al.
European Journal of Heart Failure|July 29, 2020
Prevalence and incidence of intra-ventricular conduction delays and outcomes in patients with heart failure and reduced ejection fraction: insights from PARADIGM-HF and ATMOSPHERESøren Lund Kristensen, Davide Castagno, Li Shen, et al.
American Journal of Physiology. Heart and Circulatory Physiology|October 22, 2002
Deficiency of TIMP-1 exacerbates LV remodeling after myocardial infarction in miceEsther E J M Creemers, Jeniffer N Davis, Andrea M Parkhurst, et al.
Circulation|November 20, 2014
International geographic variation in event rates in trials of heart failure with preserved and reduced ejection fractionSøren L Kristensen, Lars Køber, Pardeep S Jhund, et al.
JACC. Heart Failure|October 10, 2024
Race in Heart Failure: A Pooled Participant-Level Analysis of the Global PARADIGM-HF and PARAGON-HF TrialsHenri Lu, Brian L Claggett, Milton Packer, et al.
European Journal of Heart Failure|April 1, 2024
Interatrial shunt therapy in advanced heart failure: Outcomes from the open-label cohort of the RELIEVE-HF trialJosep Rodés-Cabau, JoAnn Lindenfeld, William T Abraham, et al.
JACC. Heart Failure|April 15, 2019
Prior Pacemaker Implantation and Clinical Outcomes in Patients With Heart Failure and Preserved Ejection FractionLi Shen, Pardeep S Jhund, Kieran F Docherty, et al.
European Journal of Heart Failure|April 17, 2023
Impact of multimorbidity on mortality in heart failure with reduced ejection fraction: which comorbidities matter most? An analysis of PARADIGM-HF and ATMOSPHEREPooja Dewan, João Pedro Ferreira, Jawad H Butt, et al.
Pageof 106